Treatment-related toxicities of apatinib in solid tumors: a meta-analysis

BACKGROUND: Apatinib is a novel small molecular drug targeting vascular endothelial growth factor receptor-2 (VEGFR-2), which is being studied in multiple tumor types. We performed a meta-analysis to quantify the overall incidence and risk of hypertension, proteinuria, and hand-foot-syndrome (HFS) i...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Ling, Ye, Xianghua, Hong, Yun, Zhang, Junyan, Dong, Yongquan, Zhao, Qiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6114950/
https://www.ncbi.nlm.nih.gov/pubmed/30181815
http://dx.doi.org/10.18632/oncotarget.24215

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6114950/
https://www.ncbi.nlm.nih.gov/pubmed/30181815
http://dx.doi.org/10.18632/oncotarget.24215

Ejemplares similares